Iovance Biotherapeutics (STU:2LB) Other Operating Expense : €-0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Iovance Biotherapeutics Other Operating Expense?

Iovance Biotherapeutics's Other Operating Expense for the three months ended in Mar. 2025 was €-0.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was €-0.0 Mil.

Iovance Biotherapeutics's quarterly Other Operating Expense increased from Sep. 2024 (€-0.0 Mil) to Dec. 2024 (€0.0 Mil) but then declined from Dec. 2024 (€0.0 Mil) to Mar. 2025 (€-0.0 Mil).

Iovance Biotherapeutics's annual Other Operating Expense increased from Dec. 2022 (€-0.0 Mil) to Dec. 2023 (€0.0 Mil) but then stayed the same from Dec. 2023 (€0.0 Mil) to Dec. 2024 (€0.0 Mil).

Iovance Biotherapeutics Other Operating Expense Historical Data

The historical data trend for Iovance Biotherapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iovance Biotherapeutics Other Operating Expense Chart

Iovance Biotherapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

Iovance Biotherapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

Iovance Biotherapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.0 Mil.

Iovance Biotherapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Iovance Biotherapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Iovance Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Iovance Biotherapeutics Inc (STU:2LB) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

IOVA:USA 0JDK:UK

Address

825 Industrial Road, Suite 100, San Carlos, CA, USA, 94070

Website

https://www.iovance.com

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Iovance Biotherapeutics Headlines

No Headlines